Patient Square Capital LP Agios Pharmaceuticals, Inc. Transaction History
Patient Square Capital LP
- $242 Billion
- Q1 2025
A detailed history of Patient Square Capital LP transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Patient Square Capital LP holds 139,732 shares of AGIO stock, worth $4.67 Million. This represents 1.69% of its overall portfolio holdings.
Number of Shares
139,732
Previous 121,732
14.79%
Holding current value
$4.67 Million
Previous $4 Billion
2.35%
% of portfolio
1.69%
Previous 1.5%
Shares
2 transactions
Others Institutions Holding AGIO
# of Institutions
237Shares Held
60.1MCall Options Held
323KPut Options Held
367K-
Farallon Capital Management LLC San Francisco, CA5.7MShares$191 Million0.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$187 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$162 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$117 Million2.39% of portfolio
-
State Street Corp Boston, MA2.45MShares$81.9 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.83B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...